Precision psychiatry aims to move beyond traditional symptom-based diagnostic frameworks which group biologically heterogeneous patients under the same diagnosis. By integrating contextual information, genetic data, blood biomarkers, symptom profiles and neuroimaging findings, patients can be stratified into mechanism-based subtypes. This stratification enables the identification of targeted therapeutic strategies matched to the underlying biological mechanisms. This can improve treatment efficacy and reduce the current trial-and-error approach.
Related content
One hypothesis of the cycle of anhedonia (loss of interest or pleasure) in patients with depression is illustrated in this image; this hypothesis comes from a series of experiments performed on a sample of psychology students.
As adjunctive treatment in MDD, some dopamine–serotonin receptor antagonists are associated with sedating side effects, while others are more often associated with ‘activating’ side effects.